Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Gynecol Oncol. 2020 Nov 4;160(1):99–105. doi: 10.1016/j.ygyno.2020.10.020

Table 3.

Recurrence Pattern Analysis Using Competing Risk Methodology. A. Hematogenous Recurrences; B. Peritoneal Recurrences

 A. Hematogenous Recurrences
Variable Pt# Hematogenous Recurrences Death# CIF at 3Yr (95%CI) p-value
Total Cohort 140 61 2 40.8% (32.2-49.5%)
Specimen
Manipulation
  Non-morcellated 98 50 2 49.4% (38.6-60.1%) 0.002
   Morcellation 42 11 0 21.9% (8.9-34.9%)
 B. Peritoneal Recurrences
Variable Pt# Peritoneal Recurrences Death# CIF at 3Yr (95%CI) p-value
Total Cohort 140 37 2 27.8% (20-35.7%)
Specimen
Manipulation
  Non-morcellated 98 13 2 15% (7.4-22.6%) <0.001
   Morcellation 42 24 0 56.3% (40.7-72%)

Note: p-values that appear in red are significant.

CIF, Cumulative incidence of failure